Literature DB >> 10573112

Transferrin receptor overexpression enhances transferrin responsiveness and the metastatic growth of a rat mammary adenocarcinoma cell line.

P G Cavanaugh1, L Jia, Y Zou, G L Nicolson.   

Abstract

We previously found that breast cancer cell transferrin receptor expression and proliferative response to transferrin often correlated with metastatic capability. To further explore this, we transfected mammary tumor cells with a cDNA coding for the transferrin receptor and examined the effects of its overexpression on various cellular properties. A human transferrin receptor expression plasmid was made by excising the cDNA for the receptor from pcDTR1 and ligating it into the multiple cloning site of pcDNAINeo. The resulting construct was transfected into the poorly metastatic rat MTLn2 line that expresses low endogenous levels of rat transferrin receptor, and transfection-induced receptor expression was ascertained using antibodies specific for the human protein. Approximately 50% of the initial geneticin-resistant transfected MTLn2 cells overexpressed human transferrin receptor protein. High expressors were further isolated by four sequential FACS sorts. The final cell population expressed approximately 3-7 times more cell surface transferrin receptor than did vector transfected controls. Both lines proliferated at the same rate in normal (medium plus 5% FBS) culture conditions. However, in serum-free conditions, the transferrin receptor overexpressor cells displayed a pronounced proliferative response to transferrin whereas the control line did not. When injected into the mammary fat pads of female nude mice, cells from both lines formed micrometastases to the lung that were specifically visualized by immunohistochemical staining of rat cytokeratin 17. This revealed that the transferrin receptor transfected line formed larger lesions of this nature than did cells from the vector transfected controls. When injected into the tail vein of female nude mice, the transferrin receptor overexpressors likewise formed gross lung metastases of remarkably greater size than did the vector only transfectants. Overexpression of cell surface human transferrin receptor on MTLn2 cells appeared to affect their in vitro growth response to transferrin and their ability to grow at a secondary site in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573112     DOI: 10.1023/a:1006209714287

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.

Authors:  Xiao-Xin Yang; Xiang Xu; Mei-Fang Wang; Hua-Zhen Xu; Xing-Chun Peng; Ning Han; Ting-Ting Yu; Liu-Gen Li; Qi-Rui Li; Xiao Chen; Yu Wen; Tong-Fei Li
Journal:  J Nanobiotechnology       Date:  2022-05-14       Impact factor: 9.429

2.  Endogenous and transplanted small hepatocytes in retrorsine-treated/partially hepatectomized rat liver show differences in growth, phenotype, and proximity to clusters of gamma-glutamyl transpeptidase-positive host hepatocytes.

Authors:  Chise Tateno; Marie P Carreiro; Douglas C Hixson
Journal:  J Histochem Cytochem       Date:  2009-09-28       Impact factor: 2.479

Review 3.  Breast tumor metastasis: analysis via proteomic profiling.

Authors:  Steve Goodison; Virginia Urquidi
Journal:  Expert Rev Proteomics       Date:  2008-06       Impact factor: 3.940

4.  Transferrin-receptor-mediated iron accumulation controls proliferation and glutamate release in glioma cells.

Authors:  S R Chirasani; D S Markovic; M Synowitz; S A Eichler; P Wisniewski; B Kaminska; A Otto; E Wanker; M Schäfer; P Chiarugi; J C Meier; H Kettenmann; R Glass
Journal:  J Mol Med (Berl)       Date:  2008-12-09       Impact factor: 4.599

5.  Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin.

Authors:  A Bergamo; L Messori; F Piccioli; M Cocchietto; G Sava
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

6.  Characterization of triple-negative breast cancer preclinical models provides functional evidence of metastatic progression.

Authors:  Juan J Arroyo-Crespo; Ana Armiñán; David Charbonnier; Coralie Deladriere; Martina Palomino-Schätzlein; Rubén Lamas-Domingo; Jerónimo Forteza; Antonio Pineda-Lucena; María J Vicent
Journal:  Int J Cancer       Date:  2019-04-02       Impact factor: 7.396

Review 7.  From Nanoparticles to Cancer Nanomedicine: Old Problems with New Solutions.

Authors:  Chi-Ling Chiang; Ming-Huei Cheng; Chih-Hsin Lin
Journal:  Nanomaterials (Basel)       Date:  2021-06-30       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.